Literature DB >> 16501601

Expression of activated M-Ras in hemopoietic stem cells initiates leukemogenic transformation, immortalization and preferential generation of mast cells.

X Guo1, L Stratton, J W Schrader.   

Abstract

Cultures of purified hemopoietic stem cells transduced with an activated mutant of M-Ras contained abnormal cells that, despite the presence of only low levels of growth factors, generated large, dense colonies of macrophages and blast cells. Cells from these colonies survived and grew continuously in the absence of growth factors and generated clonal cell-lines that were mainly composed of well-differentiated mast cells, with a low frequency of undifferentiated cells. When transplanted into sublethally irradiated syngeneic mice, four out of four such clones gave rise to a systemic mastocytosis and mast-cell leukemia. However, the donor clones also generated low percentages of cells with the morphological and cell-surface characteristics of erythrocytes, granulocytes, monocytes and T- and B-lymphocytes. These data indicate that signals downstream of activated M-Ras are sufficient to transform hemopoietic stem cells, and while preserving their capacity to generate other cell-lineages in vivo, result in preferential generation of mast cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501601     DOI: 10.1038/sj.onc.1209452

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potential.

Authors:  C Frémin; J-P Guégan; C Plutoni; J Mahaffey; M R Philips; G Emery; S Meloche
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

2.  M-Ras induces Ral and JNK activation to regulate MEK/ERK-independent gene expression in MCF-7 breast cancer cells.

Authors:  Ariel F Castro; Tania Campos; Justin T Babcock; Marisol E Armijo; Alfonso Martínez-Conde; Roxana Pincheira; Lawrence A Quilliam
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

3.  Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34+ cells via pre-B-cell leukemia homeobox 1.

Authors:  Dehuan Ji; Pengshan Zhang; Wenjuan Ma; Yiwen Fei; Wen Xue; Yu Wang; Xiuyan Zhang; Haixia Zhou; Yun Zhao
Journal:  Oncogene       Date:  2019-09-05       Impact factor: 9.867

4.  Urinary Retention, Incontinence, and Dysregulation of Muscarinic Receptors in Male Mice Lacking Mras.

Authors:  Annette Ehrhardt; Bin Wang; Andrew C Yung; Yanni Wang; Piotr Kozlowski; Cornelis van Breemen; John W Schrader
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

5.  Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer.

Authors:  Makiko Yasumoto; Etsuko Sakamoto; Sachiko Ogasawara; Taro Isobe; Junya Kizaki; Akiko Sumi; Hironori Kusano; Jun Akiba; Takuji Torimura; Yoshito Akagi; Hiraku Itadani; Tsutomu Kobayashi; Shinichi Hasako; Masafumi Kumazaki; Shinji Mizuarai; Shinji Oie; Hirohisa Yano
Journal:  Cancer Med       Date:  2016-11-28       Impact factor: 4.452

6.  Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.

Authors:  Kouichi Tabu; Taichi Kimura; Ken Sasai; Lei Wang; Norihisa Bizen; Hiroshi Nishihara; Tetsuya Taga; Shinya Tanaka
Journal:  Mol Cancer       Date:  2010-02-19       Impact factor: 27.401

Review 7.  The Role of R-Ras Proteins in Normal and Pathologic Migration and Morphologic Change.

Authors:  Shannon M Weber; Steven L Carroll
Journal:  Am J Pathol       Date:  2021-06-07       Impact factor: 5.770

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.